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Abstract-In this paper, we derive the survival time for patients with cancerous tumors, 
and show that it follows a Weibull distribution. The result we obtain is much “cleaner” 
than the distributions previously used. 
It is well known [ 11 that the survival, or unmaintained remission time for leukemia patients 
(both human and animal) follows an exponential distribution. Specifically, the probability 
of having an unmaintained remission for time greater than f is given by the formula 
(1) 
This survival distribution depends on two parameters. The parameter A is the failure rate, 
and G is the guarantee time. The guarantee time is the minimum time needed to observe 
a failure, where failure refers to a patient going out of unmaintained remission into relapse. 
In Figures 1 and 2, we summarize the results of two experiments, one involving mice 
and the other involving humans, which verify the assertion (1). Notice first that if s(t) 
is indeed an exponential distribution, then 
Ins(t) = -h(t - G), 
i.e., the graph of lnS(t) versus t is a straight line with slope -A. Figure 1 shows plots, 
on semilogarithmic paper, of the survival distributions of mice receiving varying amounts 
of tumor cells. Twenty five mice were innoculated at each cell diluion. The slope A 
appears to be constant for all four distributions, while there is an average two day de- 
crease in the guarantee time for every tenfold decrease in tumor cell innoculum. Notice 
the excellent agreement between the observed values and the predicted values. 
Figure 2 shows the plots of the unmaintained remission times of human patients with 
acute leukemia who participated in two clinical trials. These patients were given a course 
of therapy which placed most of them in complete remission, and the therapy was then 
discontinued. The distribution denoted by 0 refers to patients who were put into remission 
with the single chemotherapeutic agent prednisone. The distribution denoted by 0 cor- 
responds to patients receiving a course of treatment termed VAMP, which consisted of 
the combination vincristine, amethoperin, 6-mercaptourine and prednisone. Statistical 
tests confirm that these t:vc distributions are indeed exponential. Notice that the failure 
rate A for VAMP is significantly smaller than the failure rate for prednisone alone. Thus 
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Fig. 1. Empirical survival distributions of untreated mice innoculated subcutaneously with serial IO-fold dilutions 
of leukemia L1210. 
VAMP is superior therapy. Treatment with prednisone alone is good for inducing re- 
mission, but rather poor for keeping patients in remission. 
In this paper we derive the survival distribution for patients with cancerous tumors. 
This result is important for two reasons: First, it sheds light on how long a patient is 
likely to live; Second, and more important, it provides us with a quantitative way of 
evaluating the efficacy of various drug and chemotherapy treatments [2-51. 
The reason that the survival time for leukemia patients satisfies an exponential distri- 
bution is that leukemia cells grow exponentially. Specifically, if n(t) denotes the number 
of leukemia cells present at time t, then 
for some positive constant 
dn 
- = kn 
dt 
(2) 
k. The situation is quite different in the case of cancerous 
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tumors. If V(t) denotes the volume of the tumor at time t, then V satisfies the Gompert- 
zian equation 
dV -= 
dt 
hepat V (3) 
for two positive constants A and (Y [6,71. Cancerous tumors deviate from exponential 
growth due to the formation of a necrotic core at the center of the tumor. The cells in the 
core die from lack of oxygen and nutrients, and only the outer portion of the tumor 
reproduces. The reproducing portion of the tumor at time t only has volume e-*‘V(t). 
The starting point for our derivation of the survival distribution for cancerous tumors 
is the assumption that the patient goes out of remission when the volume of the tumor 
exceeds a critical number 8. (This critical volume of course, varies from patient to 
patient.) This assumption is borne out in the case of leukemia patients, where the patient 
goes out of unmaintained remission when the number of leukemia cells exceeds a critical 
number N. It follows from (1) that 1nN also follows an exponential distribution. Specif- 
ically, 
Prob (1nN > n} = 
,-k74 , x > 6 
1 
,X<C3. (4) 
Here 6 is a guaranteed size, i.e., the patient will always be in remission when Inn(r) 5 
e. Our method of attack is to derive the distribution for In k. Once we know this dis- 
tribution, we can reverse our steps and find S(r). 
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Fig. 2. Distribution of unmaintained remissions for prednisone and VAMP clinical trials. q = VAMP 
(11 patients); 0 = prednisone (27 patients). 
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It is tempting of course, to use the exponential distribution (4) as the distribution for 
In 6’. However, this would lead to a nonzero probability of an infinite survival time. The 
reason for this is that v(t) grows according to the relation 
“(L) = “0 ew(l-e-='), (3 
where I/, is the initial volume of the tumor at time t = 0. A much more reasonable 
assumption is that 
x56 
Prob{lnV > x} = , b;<X<i. 
XLi 
(6) 
Here, ‘e” is a maximum for the size of the tumor. Since the limiting volume of the tumor 
is e(h’a)Vo, we may take 
i = In Pa)Vo = 1nV” + (X/(Y). (7) 
[Actually, most patients die before 45 of the limiting volume is achieved [71. However, 
the formula for s(t) is simplest when 2 is given by (7)l. 
To complete our argument, observe from (5) that the patient survives past time t only 
if 
f > voe(A/uKl-e-9 
or 
In V > lnV” + (A/cx)( 1 - ema’) . 
Thus, for In P > G, 
S(t) = e-fi 1nV” + (Xlcr)(l - eCQl) - 6 
lnV” + (X/a) - 1nV” - @/a)( 1 - e+) 
=e 
_F 1nV” + @/a)(1 - eCat) - 6 
(Xla)epaf 
where 
More precisely, 
p = 1 + (hlcr)(lnVO - 6) . 
S(t) = 1 1 e-xu3c?-1) , @a > 1 ,Pe""'l , 
(8) 
(9) 
where /3 is given by (8). 
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The survival distribution (9) is a Weibull distribution, and is much “cleaner” than the 
distributions previously used. 
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